HLB Co., Ltd.
028300
Pozycja w akcjach
#4132
HLB Co., Ltd. operates in two distinct sectors: pharmaceutical production and... HLB Co., Ltd. operates in two distinct sectors: pharmaceutical production and naval construction. In South Korea, its maritime division produces and distributes a diverse range of lifeboats, catering to offshore platforms, drilling vessels, and passenger cruise liners. Its offerings include traditional, free-fall, and rescue boat designs. Beyond lifeboats, HLB's product portfolio extends to marine and yacht engines, hooks, and a variety of specialized vessels such as rigid inflatable (RIB), patrol, fishing, aluminum, and leisure boats, as well as fishery inspection ships and general safety equipment. The company further offers comprehensive support services, including inspection and repair of lifeboats and davits, service engineering training, and the provision of spare parts. On the pharmaceutical front, HLB is engaged in the development of Riboseranib, a targeted anti-cancer agent, and Apilia, a treatment specifically for ovarian cancer. Established in 1975, HLB Co., Ltd. is headquartered in Ulsan, South Korea.
Cena akcji
$29.60
Kapitalizacja rynkowa
$3.93B
Zmiana (1 dzień)
0.12%
Zmiana (1 rok)
2.06%
Kraj
KR
Handel HLB Co., Ltd. (028300)
Kategoria
Healthcare
EPS dla HLB Co., Ltd. (028300)
EPS na dzień June 2026 TTM: $-1.12
Według najnowszych raportów finansowych i ceny akcji firmy HLB Co., Ltd., obecny EPS (TTM) wynosi $-1.12. Na koniec roku 2023 firma miała EPS w wysokości $-1.20, wzrost w porównaniu do do EPS z roku 2022, który wynosił $-0.55.
Historia EPS dla HLB Co., Ltd. od 2012 do 2026
EPS na koniec każdego roku
| Rok | EPS | Zmień |
|---|---|---|
| 2026 (TTM) | $-1.12 | 132.67% |
| 2024 | $-0.48 | -60.27% |
| 2023 | $-1.20 | 119.01% |
| 2022 | $-0.55 | -19.90% |
| 2021 | $-0.69 | 15.14% |
| 2020 | $-0.60 | 57.18% |
| 2019 | $-0.38 | -259.25% |
| 2018 | $0.24 | -240.42% |
| 2017 | $-0.17 | 40.25% |
| 2016 | $-0.12 | -194.53% |
| 2015 | $0.13 | -689.86% |
| 2014 | $-0.02 | -80.40% |
| 2013 | $-0.11 | 8.00% |
| 2012 | $-0.10 | 0.00% |
EPS dla podobnych firm lub konkurentów
| Firma | EPS | Różnica w EPS | Kraj |
|---|---|---|---|
| $17.32 | -1,650.86% |
US
|
|
| $-7.98 | 614.54% |
US
|
|
| $-5.29 | 373.67% |
AU
|
|
| - | - |
CH
|
|
| $27.74 | -2,583.88% |
NL
|
